Agilon Health, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Agilon Health reported a significant increase in net losses and a decline in Medicare Advantage and ACO beneficiaries for the fiscal year ended December 31, 2025, alongside NYSE delisting concerns.
NYSE
Agilon Health's 2024 annual report reveals a 40% increase in revenue alongside a net loss, as the company continues to invest in its Total Care Model and expand its network.
NYSE
Agilon Health's 2023 annual report reveals an 81% revenue increase driven by membership growth, alongside a net loss of $262.8 million.